By opting for injections early on, patients can potentially prevent the progression of carpal tunnel syndrome and the need for further interventions
Anecdotally, many researchers working on specific, localized injuries prefer localized administration, believing it provides a more targeted and potent effect
Suggested table of clinical case studies (to include in article): columns for patient phenotype (age, BMI, diagnosis), peptide used (dose, duration), metabolic outcomes (weight change, HOMA-IR), reproductive outcomes (ovulation, oocyte yield, pregnancy), adverse events, and follow-up duration, such as PCOS, obesity-associated anovulation, poor ovarian response, and metabolic syndrome
10.1021/es4046567